Add BrightSurf on Google Email

Science News for June 14, 2014


Will diabetes patients benefit from the Affordable Care Act?

The Affordable Care Act (ACA) offers significant benefits for diabetes patients, including non-exclusion of pre-existing conditions and access to preventive services. The law also authorizes the creation of the National Diabetes Prevention Program, delivering evidence-based lifestyle change programs to prevent type 2 diabetes.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalDiabetes Technology & Therapeutics·DateJun 14, 2014

Reversal of type 1 diabetes in mice may eventually help humans

Researchers at the University of Cincinnati have discovered a therapy that reverses new onset Type 1 diabetes in mouse models. The treatment targets the innate immune system and boosts activity of TLR4, preserving insulin-producing beta cells. This approach may hold promise for treating Type 1 diabetes in humans.

SourceUniversity of Cincinnati·DateJun 14, 2014

New post-hoc analysis shows patients with type 2 diabetes undergoing intensification of insulin therapy experienced less nighttime hypoglycemia while being treated with Januvia (Sitagliptin) compared to placebo

A post-hoc analysis of patients with type 2 diabetes found that intensification of insulin therapy with Januvia (sitagliptin) 100 mg once-daily resulted in lower incidence of nighttime hypoglycemia compared to placebo. This is a positive finding for treatment approaches aimed at lowering nocturnal hypoglycemia.

SourceGCI Health NY·DateJun 14, 2014

Research suggests benefits of canola oil for people with type 2 diabetes

A study published in Diabetes Care found that a diet rich in canola bread resulted in reduced blood glucose levels and significant reductions in LDL cholesterol. The benefits were most pronounced for those with the highest HbA1c scores, suggesting that canola oil may be a valuable addition to treatment plans.

SourceSt. Michael's Hospital·JournalDiabetes Care·DateJun 14, 2014
Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

Late-breaking observational data show patients with type 2 diabetes taking JANUVIA (sitagliptin) and metformin initiated insulin therapy at a slower rate compared to patients taking a sulfonylurea and metformin

A retrospective cohort study found patients taking JANUVIA and metformin initiated insulin therapy at a slower rate than those taking a sulfonylurea and metformin. The study suggests that real-world data may provide insight into the effects of different oral treatment regimens on the initiation of insulin use.

SourceGCI Health NY·DateJun 14, 2014

Improving diet quality reduces risk for type 2 diabetes

A study found that improving diet quality by 10% over four years reduced the risk of type 2 diabetes by about 20%. This benefit was independent of other lifestyle changes such as weight loss or increased physical activity. Improving diet quality alone has significant health benefits.

SourceAmerican Diabetes Association·DateJun 14, 2014